RFK just sacked all the top vaccination experts at the the CDC-...

RFK just sacked all the top vaccination experts at the the CDC- US Center for Diseases Control.


17 Officials making up the committee for approving vaccines.



Clean sweep . Replacing all members. Apparently they approved all vaccines before them, even those later recalled.

I wonder if they could find someone with unquestionable integrity to head up the new approval process.

Now- I suggested earlier that one Philip Krause could pop up in the future in a senior position in the US.

PHILIP R. KRAUSE, M.D., FORMER FDA DEPUTY CHIEF FOR VACCINES, JOINSMESOBLAST BOARDMelbourne, Australia; March 24 and New York, USA; March 23, 2022: Mesoblast Limited(ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases,today announced that Philip R. Krause, M.D. has joined its Board of Directors. Dr. Krause was for thepast decade Deputy Director, Office of Vaccines Research and Review (OVRR) at the US Food andDrug Administration (FDA)’s Center for Biologics Evaluation and Research (CBER). Dr. Krause iscurrently Chair of the World Health Organization COVID Vaccines Research Expert Group, and mostrecently he shared responsibility for regulatory authorizations of COVID-19 vaccines in the US.His experience encompasses regulation and development of biological products, includinginterdisciplinary team-based review process for clinical (safety and efficacy) and CMC (product quality)issues throughout the product life-cycle, through Phase 3 clinical development and post-marketingphases. At OVRR, the largest product office in CBER, Dr. Krause had joint responsibility for threeDivisions (>250 employees) in regulating vaccines and biotherapeutic products.In a 30-year career at FDA Dr. Krause has collaborated at the highest levels with international and USdomestic stakeholders including the European Medicines Association (EMA), Biomedical AdvancedResearch and Development Authority (BARDA), and the National Institutes of Health (NIH).Commenting on his appointment Dr. Krause said “I have followed Mesoblast’s development programsclosely and am very much looking forward to help guide the company as it brings its lead products tothe market. Mesoblast has a cutting-edge technology that can make a great deal of difference topatients with conditions that are highly refractory to other approaches. I believe I can make asubstantial contribution at this very important time in the company’s transition towardscommercialization.”Mesoblast Chief Executive Dr. Silviu Itescu stated “We are delighted to have Dr. Krause join ourboard. The biologics development and regulatory expertise that he brings will be invaluable in ourongoing FDA interactions on our lead and follow-on product candidates.”



For the newbies- Philip Krause resigned from the FDA because the administration was pushing vaccines onto kids without proper protocols in place.
His boss Peter Marks took over and approved the kids vaccines. Peter Marks has recently got the boot. Philip Krause's testimony is on the record and often referred to by the new hierarchy.

Part of his testimony here.....

The rapid move to mandates, which was foreshadowed by other Biden Administrationcomments20, suggested that the rapid review of the vaccine was motivated more by a desire tomandate vaccine than by other public health considerations. In this regard, as I explained above,mandates are completely outside of the purview of FDA. Thus, the citation by Dr. Marks andWoodcock of mandates as an important reason for speeding the review strongly implies thatpressure to complete the review more rapidly than Dr. Marks originally agreed to be reasonablecame from outside of the FDA. And regardless of intent, it seemed clear that the inescapableconnection between the vaccine approval and the instantaneous imposition of mandatescaused at least some in the public to wonder if the review was as thorough as expected for alicense application of this importance.


Tell me who is better qualified?






Reg